The NBA has agreed to not randomly test players for marijuana this season, a continuation of the policy that was put in place last year for the COVID-19 “restart bubble” and has remained since. Drug testing will continue for things such as human growth hormone and performance-enhancers, along with what the league calls “drugs of abuse” — such as methamphetamine, cocaine, and opiates. But the league’s agreement with the National Basketball Players Association over random marijuana tests will continue for at least another season. “We have agreed with the NBPA to extend the suspension of random testing for marijuana for the 2021-22 season and focus our random testing program on performance-enhancing products and drugs of abuse,” NBA spokesman Mike Bass said Wednesday. The agreement was revealed to players in a memo from the union, the details of which were first reported by ESPN.